Epstein-Barr virus (EBV) infects most of the world's population, is the etiological agent of Infectious mononucleosis, and is also associated with a number of malignancies including Burkitt's Lymphoma, Nasopharyngeal Carcinoma, Oral Hairy Leukoplakia, Hodgkin's Lymphoma, Adult T-Cell Lymphomas and Lymphoproliferative Diseases in AIDS patients. In vitro, EBV infects and growth transforms B-lymphocytes so that they proliferate continually into lymphoblastoid cell lines (LCLs). In these infected B-lymphocytes, EBV expresses a repertoire of latent genes. EBNA2, EBNA3A and 3C and LMP1 are essential for B lymphocyte transformation. The increase in the number of immune compromised patients in the population due to other factors like co-infection with other viral agents and genetic defects has led to an increase in the ability of EBV strains to undergo recombinantion. We propose that immune suppression provides an opportunity for selection and emergence of new EBV strains through intertypic recombination that are more potent in their ability to transform and induce proliferation of infected human cells. In this study we will investigate carcinomas and lymphomas from head and neck patients who are immune-compromised. We will specifically target samples positive for EBV based on the aggressiveness of the tumors and the immune status of the patients. The EBV genome will be analyzed for the possibility of intertypic strains of the virus from type I and type II EBV having a greater potency of transforming human B-cells. Additionally, we will create cell lines (LCLs) using the virus from these tumors to further analyze the genomes and determine the gene expression patterns of these intertypic viruses and characterize the activation markers of LCLs induced by infection with the intertypic recombinants. Finally, the new strains will be analyzed for determination of their infectivity, virulence and transformation potency. These studies will generate information for determining the potential emergence of new EBV strains in a population of immunocompromised patients with head and neck cancers and lymphomas.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE014136-06
Application #
6891380
Study Section
Special Emphasis Panel (ZDE1-YA (07))
Program Officer
Shirazi, Yasaman
Project Start
2001-08-01
Project End
2008-05-31
Budget Start
2005-06-01
Budget End
2008-05-31
Support Year
6
Fiscal Year
2005
Total Cost
$279,891
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Dzeng, Richard K; Jha, Hem Chandra; Lu, Jie et al. (2015) Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells. Mol Oncol 9:365-76
Choudhuri, Tathagata; Murakami, Masanao; Kaul, Rajeev et al. (2010) Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Cancer Biol Ther 9:1065-78
Cai, Qiliang; Verma, Subhash C; Choi, Ji-Young et al. (2010) Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency. J Virol 84:11134-44
Cai, Qiliang; Verma, Suhbash C; Lu, Jie et al. (2010) Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 78:87-142
Lan, Ke; Murakami, Masanao; Choudhuri, Tathagata et al. (2008) Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro. J Clin Virol 43:260-5
Murakami, Masanao; Meneses, Patricio I; Lan, Ke et al. (2008) The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration. Cancer Biol Ther 7:677-88
Cohen, Marc A; Basha, Suzanne R; Reichenbach, Dawn K et al. (2008) Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta Otolaryngol 128:583-9
Bajaj, Bharat G; Murakami, Masanao; Cai, Qiliang et al. (2008) Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol 82:4082-90
Murakami, Masanao; Meneses, Patricio I; Knight, Jason S et al. (2008) Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. Int J Cancer 123:500-10
Kaul, Rajeev; Murakami, Masanao; Choudhuri, Tathagata et al. (2007) Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol 81:10352-61

Showing the most recent 10 out of 31 publications